Head-to-head · Cost-Efficiency Index
Nex Gen Health Rx vs RNK Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Nex Gen Health Rx
Shoppers who want a named pharmacy and an itemized checkout, and who will read the homepage figure as the annual prepay it is.
Visit Nex Gen Health RxRNK Health
Shoppers who want one all-in monthly price for a compounded GLP-1 and are fine confirming the exact price for their dose at checkout.
Visit RNK HealthThe verdict
Nex Gen Health Rx takes it, leading the Cost-Efficiency Index 62 to 59. Nex Gen Health Rx sells compounded semaglutide at $190 and tirzepatide at $239 per 30-day supply, names the pharmacy that fills them, and advertises $99 and $149 on its homepage without saying those are twelve-month prepay rates. RNK Health still earns a C — Shoppers who want one all-in monthly price for a compounded GLP-1 and are fine confirming the exact price for their dose at checkout.
Worth knowing either way: CoreAge Rx is one of our partners and leads our leaderboard, where partners are listed first (Cost-Efficiency Index 94/100). See how it stacks up: CoreAge Rx vs Nex Gen Health Rx.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Nex Gen Health Rx | RNK Health |
|---|---|---|
| Cost-Efficiency Index | 62/100 | 59/100 |
| Semaglutide / mo | $190Per 30-day supply month-to-month (the homepage's $99 is the 360-day prepay rate) | From $197/moCompounded, month to month |
| Tirzepatide / mo | $239Per 30-day supply month-to-month (the homepage's $149 is the 360-day prepay rate) | From $297/moCompounded, month to month |
| Semaglutide / yr (modeled) | $2,280 | $2,364 |
| Tirzepatide / yr (modeled) | $2,868 | $3,564 |
| Coverage | Coverage not published | Not published (US only) |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #265 | #269 |
Nex Gen Health Rx
62/100Where the value is
- Names its pharmacy, Manifest Pharmacy, with a street address, and states the 503A class on the product pages
- The checkout itemizes what the price already covers, showing doctor support and monitoring at $99 and overnight shipping at $40 both marked free
- Full 30-, 90-, 180- and 360-day price ladders for both molecules are shown on the product page, and checkout charges the same total
The tradeoffs
- The homepage prints "for as low as $99.00 a month" and "$149.00 a month" with no basis stated; the basis appears only on a separate landing page, and it is a twelve-month plan paid in full
- That landing page sells $99 as "every month", "fixed price" and "price never increases" while its own fine print makes it conditional on $1,188 paid upfront
RNK Health
59/100Where the value is
- One monthly price covers the medication, the physician consultation and prescription, syringes and wipes, and shipping, with no separate membership or visit fee
- Month to month: you can cancel, pause or skip from your account, and it emails the upcoming amount 7 days before each renewal
- Both compounded semaglutide and tirzepatide, with NAD+, sermorelin, B12 and naltrexone available on the same account
The tradeoffs
- Both prices are "from" figures and the pages don't say what a higher dose costs, so confirm the price for your dose at checkout
- Fees are non-refundable once you submit the intake, unless a provider finds you ineligible or the medication arrives damaged or wrong
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.